Production (Stage)
Fractyl Health, Inc.
GUTS
$2.06
-$0.11-5.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -132.97% | -96.68% | -127.26% | -141.25% | -8.47% |
| Total Depreciation and Amortization | 422.29% | 454.92% | 200.00% | 127.95% | -42.81% |
| Total Amortization of Deferred Charges | -- | -- | -98.24% | -- | -- |
| Total Other Non-Cash Items | 432.43% | -168.56% | -157.48% | -219.11% | -187.34% |
| Change in Net Operating Assets | -0.49% | 1,002.53% | 798.14% | 99.88% | 119.48% |
| Cash from Operations | -136.70% | -203.10% | -187.27% | -170.14% | -6.59% |
| Capital Expenditure | 14.07% | -521.48% | -892.86% | -2,126.39% | -1,714.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 14.07% | -521.48% | -892.86% | -2,126.39% | -1,714.86% |
| Total Debt Issued | -- | -- | -100.00% | -- | 183.26% |
| Total Debt Repaid | -258.54% | -133.75% | -6.33% | -2,475.00% | 98.98% |
| Issuance of Common Stock | -99.34% | 473,840.91% | 2,082,120.00% | 305,476.47% | 58,423.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -196.37% | -771.25% | -- | -- |
| Cash from Financing | -99.69% | 269.29% | 259.75% | 427,926.67% | 5,762.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.97% | 515.97% | 451.24% | 486.95% | 421.58% |